BRAF and melanoma: However, despite their proven efficacy, it was demonstrated that treatment of melanomas with BRAF inhibitors renders them dependent on ATP generation by the mitochondria and the association with inhibitors of oxidative phosphorylation may enhance the effect of BRAF inhibitors in melanoma patients [33].